View in EDS

A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.

Saved in:
Bibliographic Details
Title: A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.
Authors: Harding FA; Genencor International, 925 Page Mill Road, Palo Alto, California 94304, USA., Liu AD, Stickler M, Razo OJ, Chin R, Faravashi N, Viola W, Graycar T, Yeung VP, Aehle W, Meijer D, Wong S, Rashid MH, Valdes AM, Schellenberger V
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2005 Nov; Vol. 4 (11), pp. 1791-800.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Print ISSN: 1535-7163 (Print) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 16276001
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Harding+FA%22">Harding FA</searchLink>; Genencor International, 925 Page Mill Road, Palo Alto, California 94304, USA.<br /><searchLink fieldCode="AU" term="%22Liu+AD%22">Liu AD</searchLink><br /><searchLink fieldCode="AU" term="%22Stickler+M%22">Stickler M</searchLink><br /><searchLink fieldCode="AU" term="%22Razo+OJ%22">Razo OJ</searchLink><br /><searchLink fieldCode="AU" term="%22Chin+R%22">Chin R</searchLink><br /><searchLink fieldCode="AU" term="%22Faravashi+N%22">Faravashi N</searchLink><br /><searchLink fieldCode="AU" term="%22Viola+W%22">Viola W</searchLink><br /><searchLink fieldCode="AU" term="%22Graycar+T%22">Graycar T</searchLink><br /><searchLink fieldCode="AU" term="%22Yeung+VP%22">Yeung VP</searchLink><br /><searchLink fieldCode="AU" term="%22Aehle+W%22">Aehle W</searchLink><br /><searchLink fieldCode="AU" term="%22Meijer+D%22">Meijer D</searchLink><br /><searchLink fieldCode="AU" term="%22Wong+S%22">Wong S</searchLink><br /><searchLink fieldCode="AU" term="%22Rashid+MH%22">Rashid MH</searchLink><br /><searchLink fieldCode="AU" term="%22Valdes+AM%22">Valdes AM</searchLink><br /><searchLink fieldCode="AU" term="%22Schellenberger+V%22">Schellenberger V</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2005 Nov; Vol. 4 (11), pp. 1791-800.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1535-7163 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=16276001
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-05-0189
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1791
    Titles:
      – TitleFull: A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Harding FA
      – PersonEntity:
          Name:
            NameFull: Liu AD
      – PersonEntity:
          Name:
            NameFull: Stickler M
      – PersonEntity:
          Name:
            NameFull: Razo OJ
      – PersonEntity:
          Name:
            NameFull: Chin R
      – PersonEntity:
          Name:
            NameFull: Faravashi N
      – PersonEntity:
          Name:
            NameFull: Viola W
      – PersonEntity:
          Name:
            NameFull: Graycar T
      – PersonEntity:
          Name:
            NameFull: Yeung VP
      – PersonEntity:
          Name:
            NameFull: Aehle W
      – PersonEntity:
          Name:
            NameFull: Meijer D
      – PersonEntity:
          Name:
            NameFull: Wong S
      – PersonEntity:
          Name:
            NameFull: Rashid MH
      – PersonEntity:
          Name:
            NameFull: Valdes AM
      – PersonEntity:
          Name:
            NameFull: Schellenberger V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2005 Nov
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 1535-7163
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1